User profiles for L. Jehi

Lara Jehi, MD

Cleveland Clinic Foundation
Verified email at ccf.org
Cited by 9692

Neuromodulation in epilepsy: state-of-the-art approved therapies

…, S Rheims, LJ Hirsch, A Sokolov, L Jehi - The Lancet …, 2021 - thelancet.com
Three neuromodulation therapies have been appropriately tested and approved in refractory
focal epilepsies: vagus nerve stimulation (VNS), deep brain stimulation of the anterior …

Temporal patterns and mechanisms of epilepsy surgery failure

I Najm, L Jehi, A Palmini, J Gonzalez‐Martinez… - …, 2013 - Wiley Online Library
… seizures from the temporal tissue immediately adjacent to the surgical bed (Jehi et al., 2010).
This inverse correlation between early … Lara Jehi receives research funding from UCB Inc. …

The epileptogenic zone: concept and definition

L Jehi - Epilepsy currents, 2018 - journals.sagepub.com
A “concept” refers to what exists in the mind as a representation (as in something comprehended)
or as a formulation (as in a plan). It is generally understood as “any idea of what a …

Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)

…, A Milinovich, LG Svensson, L Jehi… - JAMA …, 2020 - jamanetwork.com
Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) pandemic …

[HTML][HTML] New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

…, J Zhao, W Martin, A Kallianpur, MK Chung, L Jehi… - BMC medicine, 2020 - Springer
… The inhibitors of endosomal acidification such as CatB/L inhibitor E-64D and
hydroxychloroquine/chloroquine may only work for TMPRSS2-absence patients who are infected by …

[HTML][HTML] A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

…, T Stappenbeck, T Chan, C Eng, JU Jung, L Jehi… - PLoS …, 2020 - journals.plos.org
… By matching the enzymes of the differential metabolites and the proteins in the PPI network,
we found 3 key metabolites: arachidonate, L-arginine, and L-citrulline. L-arginine and L-…

Individualizing risk prediction for positive coronavirus disease 2019 testing: results from 11,672 patients

L Jehi, X Ji, A Milinovich, S Erzurum, BP Rubin… - Chest, 2020 - Elsevier
… Author links open overlay panel Lara Jehi MD, MHCDS a , Xinge Ji MS b , Alex Milinovich
MS b , Serpil Erzurum MD c , Brian P. Rubin MD, PhD d , Steve Gordon MD e , James B. …

Alpha to Omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants

…, D Rhoads, GW Procop, JS Ko, L Jehi… - The Journal of …, 2023 - academic.oup.com
Background Four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
predominated in the United States since 2021. Understanding disease severity related to …

Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against …

L Jehi, N Jette, CS Kwon, CB Josephson… - …, 2022 - Wiley Online Library
Epilepsy surgery is the treatment of choice for patients with drug‐resistant seizures. A timely
evaluation for surgical candidacy can be life‐saving for patients who are identified as …

Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis

L Jehi, R Yardi, K Chagin, L Tassi, GL Russo… - The Lancet …, 2015 - thelancet.com
Background Half of patients who have resective brain surgery for drug-resistant epilepsy
have recurrent postoperative seizures. Although several single predictors of seizure outcome …